SCHEMBL27635537

SCHEMBL27635537

Cc1cc(-c2ccccc2)c(C)cc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.49
ESR2 Q92731 1/20 0.48
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 2/20 0.48
CYP3A4 P08684 3/20 0.48
TSHR P16473 2/20 0.48
MAPK1 P28482 2/20 0.48
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
TDP1 Q9NUW8 3/20 0.43
CYP2A6 P11509 1/20 0.42
CYP2B6 P20813 1/20 0.42
SMARCA2 P51531 2/20 0.39
SMARCA4 P51532 2/20 0.39
PBRM1 Q86U86 2/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952446 0.89 PDE4A (0.52) DHFRESR2ALDH1A1HSD17B10CYP3A4
SCHEMBL6572093 0.87 PDE4A (0.50) DHFRESR2ALDH1A1HSD17B10CYP3A4
SCHEMBL4830408 0.86 ESR2 (0.60) DHFRESR2ALDH1A1HSD17B10TSHR
Hydrochloric Acid SCHEMBL6570955 0.85 PDE4A (0.49) DHFRESR2ALDH1A1HSD17B10CYP3A4
SCHEMBL6572246 0.79 BACE1 (0.58) DHFRESR2ALDH1A1HSD17B10CYP3A4
SCHEMBL656284 0.79 ALDH1A1 (0.46) DHFRESR2ALDH1A1HSD17B10CYP3A4
SCHEMBL28456459 0.79 PGR (0.45) DHFRALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL5547251 0.79 ESR2 (0.58) DHFRESR2ALDH1A1HSD17B10TSHR
SCHEMBL4834991 0.78 ESR2 (0.48) DHFRESR2ALDH1A1CYP3A4MAPK1
SCHEMBL25742905 0.78 ESR2 (0.48) DHFRESR2ALDH1A1MAPK1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1826121-B Application of phenyl and pyridyl derivatives in preparation of drugs for regulating calcium ion release and activating calcium ion channels SYNTA PHARMACEUTICALS CORP 2013-05-29 CN claimed
CN-102793692-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP 2012-11-28 CN claimed
CN-101947218-A The method of modulating calcium ion-release-activated calcium ion channels SYNTA PHARMACEUTICALS CORP 2011-01-19 CN claimed
CN-1826121-A Method for regulating and controlling calcium ion release to activate calcium ion channel SYNTA PHARMACEUTICALS CORP (US) 2006-08-30 CN claimed
CN-1826120-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP (US) 2006-08-30 CN claimed
CN-102793692-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP 2012-11-28 CN disclosed
CN-101947218-A The method of modulating calcium ion-release-activated calcium ion channels SYNTA PHARMACEUTICALS CORP 2011-01-19 CN disclosed
CN-1826121-A Method for regulating and controlling calcium ion release to activate calcium ion channel SYNTA PHARMACEUTICALS CORP (US) 2006-08-30 CN disclosed
CN-1826120-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP (US) 2006-08-30 CN disclosed